USA: FDA Examines Loosening of Peptide Regulations
The U.S. Food and Drug Administration (FDA) is currently reviewing whether to expand access to certain peptide products. This discussion is being driven by Robert F. Kennedy Jr., who heads the U.S. Department of Health and Human Services, and advocates for less stringent regulations. However, the safety and efficacy of these substances remain disputed.